# US 2024/0189298 A1 · Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0189298 A1
- Document ID: US20240189298A1
- Status: Published application
- Kind: A1
- Application number: 18/436,836
- Filed: 2024-02-08
- Published: 2024-06-13
- Earliest claimed: 2011-02-10
- Assignees: Exelixis, Inc.
- Applicants: Exelixis, Inc.
- Inventors: Jo Ann Wilson; Khalid Shah
- Web page: https://patentgrep.com/patent/US20240189298A1

## CPC

- A61K 31/47: Quinolines; Isoquinolines
- A61P 35/00: Antineoplastic agents
- C07D 215/233: only one oxygen atom which is attached in position 4
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The present invention is directed to processes for making and compositions containing quinolines such as formula I or pharmaceutically acceptable salts thereof wherein: X1 is H, Br, CI, or X2 is H, Br, CI, or n1 is 1-2; and n2 is 1-2.

## Claims

### Claim at position 1

1-34. (canceled)

### Claim 35

A pharmaceutical composition for oral administration comprising Compound IB:
and a pharmaceutically acceptable carrier, wherein the pharmaceutical composition is a tablet or a capsule, and wherein the pharmaceutical composition contains 100 ppm or less of 6,7-dimethoxy-quinoline-4-ol.

### Claim 36 (depends on 1)

The pharmaceutical composition of claim 1, wherein the pharmaceutical composition contains 50 ppm or less of 6,7-dimethoxy-quinoline-4-ol.

### Claim 37 (depends on 2)

The pharmaceutical composition of claim 2, wherein the pharmaceutical composition contains 25 ppm or less of 6,7-dimethoxy-quinoline-4-ol.

### Claim 38 (depends on 3)

The pharmaceutical composition of claim 3, wherein the pharmaceutical composition contains 10 ppm or less of 6,7-dimethoxy-quinoline-4-ol.

### Claim 39 (depends on 4)

The pharmaceutical composition of claim 4, wherein the pharmaceutical composition contains 5 ppm or less of 6,7-dimethoxy-quinoline-4-ol.

### Claim 40

A method of treating cancer, comprising administering to a subject in need thereof a pharmaceutical composition comprising Compound IB:
and a pharmaceutically acceptable carrier, wherein the pharmaceutical composition is a tablet or a capsule, and wherein the pharmaceutical composition contains 100 ppm or less of 6,7-dimethoxy-quinoline-4-ol.

### Claim 41 (depends on 6)

The method of claim 6, wherein the pharmaceutical composition contains 50 ppm or less of 6,7-dimethoxy-quinoline-4-ol.

### Claim 42 (depends on 7)

The method of claim 7, wherein the pharmaceutical composition contains 25 ppm or less of 6,7-dimethoxy-quinoline-4-ol.

### Claim 43 (depends on 8)

The method of claim 8, wherein the pharmaceutical composition contains 10 ppm or less of 6,7-dimethoxy-quinoline-4-ol.

### Claim 44 (depends on 9)

The method of claim 9, wherein the pharmaceutical composition contains 5 ppm or less of 6,7-dimethoxy-quinoline-4-ol.

### Claim 45 (depends on 6)

The method of claim 6, wherein the cancer is renal cancer.

### Claim 46 (depends on 6)

The method of claim 6, wherein the cancer is prostate cancer.

### Claim 47 (depends on 6)

The method of claim 6, wherein the cancer is hepatocellular carcinoma.

### Claim 48 (depends on 7)

The method of claim 7, wherein the cancer is renal cancer.

### Claim 49 (depends on 7)

The method of claim 7, wherein the cancer is prostate cancer.

### Claim 50 (depends on 7)

The method of claim 7, wherein the cancer is hepatocellular carcinoma.

### Claim 51 (depends on 8)

The method of claim 8, wherein the cancer is renal cancer.

### Claim 52 (depends on 8)

The method of claim 8, wherein the cancer is prostate cancer.

### Claim 53 (depends on 8)

The method of claim 8, wherein the cancer is hepatocellular carcinoma.

### Claim 54 (depends on 9)

The method of claim 9, wherein the cancer is renal cancer.

### Claim 55 (depends on 9)

The method of claim 9, wherein the cancer is prostate cancer.

### Claim 56 (depends on 9)

The method of claim 9, wherein the cancer is hepatocellular carcinoma.
